Cleared Traditional

K002604 - CENTURION 2000 CENTRAL STATION ARRHYTHMIA PATIENT MONITORING SYSTEM

K002604 is an FDA 510(k) clearance for CENTURION 2000 CENTRAL STATION ARRHYTHM..., manufactured by Invivo Research, Inc.. The device is a Class 2 Cardiovascular device with product code DSI cleared through the Traditional 510(k) pathway after a 534-day FDA review.

K002604 · Invivo Research, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2002
Decision
534d
Days
Class 2
Risk

K002604 is an FDA 510(k) clearance for the CENTURION 2000 CENTRAL STATION ARRHYTHMIA PATIENT MONITORING SYSTEM. Classified as Detector And Alarm, Arrhythmia (product code DSI), Class II - Special Controls.

Submitted by Invivo Research, Inc. (Orlando, US). The FDA issued a Cleared decision on February 7, 2002 after a review of 534 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Invivo Research, Inc. devices

FDA 510(k) Submission Details - K002604

510(k) Number K002604 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 2000
Decision Date February 07, 2002
Days to Decision 534 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
409d slower than avg
Panel avg: 125d · This submission: 534d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSI Device Classification - Class 2, Special Controls

Product Code DSI Detector And Alarm, Arrhythmia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSI Detector And Alarm, Arrhythmia

All 275
Devices cleared under the same product code (DSI) and FDA review panel - the closest regulatory comparables to K002604.
MODIFICATION OF PHILIPS COMPONENT COMPACT MONITOR, RELEASE A.03, MODEL M1275B
K021300 · Philips Medical Systems · May 2002
ST/AR ST AND ARRHYTHMIA SOFTWARE, RELEASE E.I.
K021251 · Philips Medical Systems · May 2002
SOLAR 8000M SYSTEM
K012467 · General Electric Medical Systems Information Techn · Feb 2002
FUKUDA DENSHI DYNASCOPE MODEL DS-5700
K020084 · Fukuda Denshi USA, Inc. · Feb 2002
PHILLIPS M1175A/76A/77A COMPONENT MONITORING SYSTEM
K014159 · Philips Medical Systems, Inc. · Jan 2002
MODIFICATION TO:ESCORT VISION CENTRAL STATION TELEMETRY SYSTEM, MODEL 20500
K012336 · Medical Data Electronics · Oct 2001